FI970230A0 - Menetelmä proteiinien, kuten yhdistelmä-DNA-hirudiinin tai -epidermaalisen kasvutekijän laskostamiseksi - Google Patents
Menetelmä proteiinien, kuten yhdistelmä-DNA-hirudiinin tai -epidermaalisen kasvutekijän laskostamiseksiInfo
- Publication number
- FI970230A0 FI970230A0 FI970230A FI970230A FI970230A0 FI 970230 A0 FI970230 A0 FI 970230A0 FI 970230 A FI970230 A FI 970230A FI 970230 A FI970230 A FI 970230A FI 970230 A0 FI970230 A0 FI 970230A0
- Authority
- FI
- Finland
- Prior art keywords
- growth factor
- epidermal growth
- recombinant hirudin
- folding proteins
- proteins
- Prior art date
Links
- 102000009024 Epidermal Growth Factor Human genes 0.000 title 1
- 101800003838 Epidermal growth factor Proteins 0.000 title 1
- 229940116977 epidermal growth factor Drugs 0.000 title 1
- WQPDUTSPKFMPDP-OUMQNGNKSA-N hirudin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC(OS(O)(=O)=O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]2CSSC[C@@H](C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@H](C(NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N2)=O)CSSC1)C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)C(C)C)[C@@H](C)O)CSSC1)C(C)C)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 WQPDUTSPKFMPDP-OUMQNGNKSA-N 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Crystallography & Structural Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP94810437 | 1994-07-25 | ||
PCT/EP1995/002720 WO1996003425A1 (en) | 1994-07-25 | 1995-07-12 | Process for folding of proteins like recombinant hirudin or epidermal growth factor |
Publications (2)
Publication Number | Publication Date |
---|---|
FI970230A0 true FI970230A0 (fi) | 1997-01-20 |
FI970230A FI970230A (fi) | 1997-01-20 |
Family
ID=8218291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI970230A FI970230A (fi) | 1994-07-25 | 1997-01-20 | Menetelmä proteiinien, kuten yhdistelmä-DNA-hirudiinin tai -epidermaalisen kasvutekijän laskostamiseksi |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0804461A1 (xx) |
JP (1) | JPH11505507A (xx) |
AU (1) | AU3109795A (xx) |
CA (1) | CA2194177A1 (xx) |
FI (1) | FI970230A (xx) |
IL (1) | IL114699A0 (xx) |
NO (1) | NO970081D0 (xx) |
WO (1) | WO1996003425A1 (xx) |
ZA (1) | ZA956137B (xx) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3734634B2 (ja) | 1999-03-03 | 2006-01-11 | ヒゲタ醤油株式会社 | タンパク質の活性化方法及び該装置 |
US7521479B2 (en) | 2001-04-16 | 2009-04-21 | Panacea Pharmaceuticals, Inc. | Methods of treating prion disease in mammals |
AU2003223936A1 (en) * | 2002-05-17 | 2003-12-02 | Kobenhavns Universitet | Method for purifying denatured proteins having a desired disulfide bond configuration |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR79124B (xx) * | 1982-12-22 | 1984-10-02 | Genentech Inc | |
ES8800957A1 (es) * | 1985-02-22 | 1987-12-01 | Monsanto Co | Un metodo para la solubilizacion y renaturalizacion de proteina somatotropina |
GB8927546D0 (en) * | 1989-12-06 | 1990-02-07 | Ciba Geigy | Process for the production of biologically active tgf-beta |
DE69229202T2 (de) * | 1991-02-26 | 2000-01-05 | Ajinomoto Co., Inc. | Verfahren zur reinigung von menschlichem bcdf |
US5290920A (en) * | 1992-04-16 | 1994-03-01 | Allelix Biopharmaceuticals Inc. | Method of purifying human epidermal growth factor |
-
1995
- 1995-07-12 AU AU31097/95A patent/AU3109795A/en not_active Abandoned
- 1995-07-12 CA CA002194177A patent/CA2194177A1/en not_active Abandoned
- 1995-07-12 WO PCT/EP1995/002720 patent/WO1996003425A1/en not_active Application Discontinuation
- 1995-07-12 EP EP95926859A patent/EP0804461A1/en not_active Withdrawn
- 1995-07-12 JP JP8505402A patent/JPH11505507A/ja active Pending
- 1995-07-24 ZA ZA956137A patent/ZA956137B/xx unknown
- 1995-07-24 IL IL11469995A patent/IL114699A0/xx unknown
-
1997
- 1997-01-09 NO NO970081A patent/NO970081D0/no unknown
- 1997-01-20 FI FI970230A patent/FI970230A/fi not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1996003425A1 (en) | 1996-02-08 |
EP0804461A1 (en) | 1997-11-05 |
IL114699A0 (en) | 1995-11-27 |
AU3109795A (en) | 1996-02-22 |
ZA956137B (en) | 1996-03-07 |
CA2194177A1 (en) | 1996-02-08 |
NO970081L (no) | 1997-01-09 |
FI970230A (fi) | 1997-01-20 |
JPH11505507A (ja) | 1999-05-21 |
NO970081D0 (no) | 1997-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69636831D1 (de) | Verfahren zur herstellung heteromultimerer polypeptide | |
DE69826705D1 (de) | Verfahren zur dermalen verabreichung von polypeptiden | |
DE59813187D1 (de) | Verfahren zur herstellung von polypeptiden mit geeigneter glykosilierung | |
FI974432A0 (fi) | Grampositiivisten bakteerien käyttö rekombinanttiproteiinien ilmentämiseksi | |
AU7865591A (en) | Method and means for extending the host range of insecticidal proteins | |
DE59405908D1 (de) | Verfahren zur herstellung von umsetzungsprodukten aus polyasparaginsäureimid und aminosäuren und ihre verwendung | |
DE69214905D1 (de) | Verfahren zur Kontrolle von elektroosmotischem Abfluss | |
DE69300156D1 (de) | Gehänge zur Verwendung in Förderern. | |
FI954805A (fi) | Menetelmiä insuliininkaltaisen kasvutekijän sitojaproteiinien käyttämiseksi | |
DE59601822D1 (de) | Verfahren zur herstellung von weizenproteinhydrolysaten | |
AU1683795A (en) | Method for determining protein tertiary structure | |
DE69830556D1 (de) | Verfahren zur Bestimmung von glykosylierten Proteinen | |
DE59705527D1 (de) | Förderanlage zur Förderung von Hohlkörpern | |
ATE245192T1 (de) | Verfahren zur herstellung von gereinigten papillomavirus proteinen | |
DE59101580D1 (de) | Trägergebundene rekombinante proteine, verfahren zur herstellung und verwendung als immunogene und vakzine. | |
FI921059A (fi) | Menetelmä hyötyproteiinien erittämiseksi hiivoista | |
DE69706119D1 (de) | Verfahren zur Herstellung von mit Succinimidgruppen modifizierten Polyoxyalkylenderivaten | |
FI940316A (fi) | Menetelmä heraproteiinien fraktioimiseksi | |
FI970230A (fi) | Menetelmä proteiinien, kuten yhdistelmä-DNA-hirudiinin tai -epidermaalisen kasvutekijän laskostamiseksi | |
DE69906173D1 (de) | Verfahren zur Herstellung von Oxyalkylenderivaten in Gegenwart von Phosphinoxiden | |
FI954316A0 (fi) | Menetelmä DNA-vajauksen määrittämiseksi | |
FI955000A0 (fi) | Menetelmä polypeptidin läsnäolon paljastamiseksi ja sen muuttamiseksi | |
FI940846A0 (fi) | Menetelmä heraproteiinien eristämiseksi | |
DE69434914D1 (de) | Verfahren und zusammensetzungen zur herstellung von rekombinantem osteogenischem protein | |
ATE194144T1 (de) | Verfahren zur reinigung von glykoproteinen wie erythropoietin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or assigment of application |
Owner name: NOVARTIS AG |
|
FD | Application lapsed |